Literature DB >> 28916665

Integrin α4 Overexpression on Rat Mesenchymal Stem Cells Enhances Transmigration and Reduces Cerebral Embolism After Intracarotid Injection.

Li-Li Cui1, Franziska Nitzsche1, Evgeny Pryazhnikov1, Marina Tibeykina1, Laura Tolppanen1, Jussi Rytkönen1, Tuulia Huhtala1, Jing-Wei Mu1, Leonard Khiroug1, Johannes Boltze1, Jukka Jolkkonen2.   

Abstract

BACKGROUND AND
PURPOSE: Very late antigen-4 (integrin α4β1)/vascular cell adhesion molecule-1 mediates leukocyte trafficking and transendothelial migration after stroke. Mesenchymal stem cells (MSCs) typically express integrin β1 but insufficient ITGA4 (integrin α4), which limits their homing after intravascular transplantation. We tested whether ITGA4 overexpression on MSCs increases cerebral homing after intracarotid transplantation and reduces MSC-borne cerebral embolism.
METHODS: Rat MSCs were lentivirally transduced to overexpress ITGA4. In vitro transendothelial migration was assessed using a Boyden chamber assay. Male Wistar rats intracarotidly received 0.5×106 control or modified MSCs 24 hours after sham or stroke surgery. In vivo behavior of MSCs in the cerebral vasculature was observed by intravital microscopy and single-photon emission computed tomography for up to 72 hours.
RESULTS: Transendothelial migration of ITGA4-overexpressing MSCs was increased in vitro. MSCs were passively entrapped in microvessels in vivo and occasionally formed large cell aggregates causing local blood flow interruptions. MSCs were rarely found in perivascular niches or parenchyma at 72 hours post-transplantation, but ITGA4 overexpression significantly decreased cell aggregation and ameliorated the evoked cerebral embolism in stroke rats.
CONCLUSIONS: ITGA4 overexpression on MSCs enhances transendothelial migration in vitro, but not in vivo, although it improves safety after intracarotid transplantation into stroke rats.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  integrin α4β1; intracranial embolism; leukocytes; mesenchymal stromal cells; stroke; transendothelial and transepithelial migration; vascular cell adhesion molecule-1

Mesh:

Substances:

Year:  2017        PMID: 28916665     DOI: 10.1161/STROKEAHA.117.017809

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

Review 1.  Intra-Arterial Delivery of Cell Therapies for Stroke.

Authors:  Raphael Guzman; Miroslaw Janowski; Piotr Walczak
Journal:  Stroke       Date:  2018-04-18       Impact factor: 7.914

Review 2.  Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases.

Authors:  Milena B P Soares; Renata G J Gonçalves; Juliana F Vasques; Almir J da Silva-Junior; Fernanda Gubert; Girlaine Café Santos; Thaís Alves de Santana; Gabriela Louise Almeida Sampaio; Daniela Nascimento Silva; Massimo Dominici; Rosalia Mendez-Otero
Journal:  Front Mol Neurosci       Date:  2022-06-16       Impact factor: 6.261

Review 3.  Ischemic Brain Stroke and Mesenchymal Stem Cells: An Overview of Molecular Mechanisms and Therapeutic Potential.

Authors:  Yang Jingli; Wang Jing; Yasmeen Saeed
Journal:  Stem Cells Int       Date:  2022-05-25       Impact factor: 5.131

4.  Mesenchymal stem cell aggregation mediated by integrin α4/VCAM-1 after intrathecal transplantation in MCAO rats.

Authors:  Ye Ran; Yankai Dong; Yuejiao Li; Jundong Xie; Shubin Zeng; Chuanlei Liang; Wei Dai; Wenjing Tang; Yaojiong Wu; Shengyuan Yu
Journal:  Stem Cell Res Ther       Date:  2022-10-22       Impact factor: 8.079

Review 5.  The impact of hypoxic-ischemic brain injury on stem cell mobilization, migration, adhesion, and proliferation.

Authors:  Stephanie M Parry; Eric S Peeples
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

6.  Particle-based artificial three-dimensional stem cell spheroids for revascularization of ischemic diseases.

Authors:  Ran Zhang; Wenya Luo; Yue Zhang; Dashuai Zhu; Adam C Midgley; Hao Song; Anila Khalique; Haoqi Zhang; Jie Zhuang; Deling Kong; Xinglu Huang
Journal:  Sci Adv       Date:  2020-05-06       Impact factor: 14.136

Review 7.  Improved therapeutics of modified mesenchymal stem cells: an update.

Authors:  Dickson Kofi Wiredu Ocansey; Bing Pei; Yongmin Yan; Hui Qian; Xu Zhang; Wenrong Xu; Fei Mao
Journal:  J Transl Med       Date:  2020-01-30       Impact factor: 5.531

8.  Genetic analysis of the molecular regulation of electric fields-guided glia migration.

Authors:  Li Yao; Teresa Shippy; Yongchao Li
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

9.  Cell heterogeneity, rather than the cell storage solution, affects the behavior of mesenchymal stem cells in vitro and in vivo.

Authors:  Yong-Hong Wang; Ya-Chao Tao; Dong-Bo Wu; Meng-Lan Wang; Hong Tang; En-Qiang Chen
Journal:  Stem Cell Res Ther       Date:  2021-07-13       Impact factor: 6.832

10.  Increased migratory and homing abilities of neural and mesenchymal stem cell populations by transient cell modifications: Preclinical progress and clinical relevance.

Authors:  Johannes Boltze; Nadine Didwischus; Shen Li; Jukka Jolkkonen; Akihiko Taguchi
Journal:  EBioMedicine       Date:  2020-09-24       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.